share_log

Morgan Stanley Upgrades Centessa Pharmaceuticals to Equal-Weight, Raises Price Target to $8

Morgan Stanley Upgrades Centessa Pharmaceuticals to Equal-Weight, Raises Price Target to $8

摩根士丹利將Centessa Pharmicals上調至同等權重,將目標股價提高至8美元
Benzinga ·  2023/10/26 05:07

Morgan Stanley analyst Matthew Harrison upgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Underweight to Equal-Weight and raises the price target from $4 to $8.

摩根士丹利分析師馬修·哈裡森將Centessa PharmPharmticals(納斯達克股票代碼:CNTA)的評級從減持上調至持平,並將目標價從4美元上調至8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論